Ra Pharmaceuticals, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/19 FY 2019 – amended

ended 12/31/19 FY 2019

ended 09/30/19 Q3

ended 06/30/19 Q2

ended 03/31/19 Q1

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

New Enterprise Associates 13 LP

Kerins Patrick J, Sandell Scott D, Baskett Forest, New Enterprise Associates 13 LP, NEA 13 GP, Ltd, NEA Partners 13, Limited Partnership

Mathers Edward T

Treco Douglas A

Lubner David Charles

News Filter

UCB Completes the Acquisition of Ra Pharmaceuticals – To Deliver Differentiated Therapies to Patients

Material Definitive Agreement, Financial Statements or Exhibits

Shareholder Vote Results, Other Events

Proxies Filter

Additional info about upcoming vote

Proxy related to merger

Preliminary proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Approval for listing by National Association of Securities Dealers